SCHEMBL6643375

SCHEMBL6643375

CC(C)(C)OC(=O)N(CCn1cccn1)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.41
LMNA P02545 4/20 0.38
MAPT P10636 3/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
GAA P10253 1/20 0.38
MAPK1 P28482 1/20 0.36
F2 P00734 3/20 0.35
POLB P06746 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
AR P10275 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
CRHBP P24387 1/20 0.34
ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6648464 0.86 POLB (0.42) ALDH1A1LMNAMAPTKMT2AMEN1
SCHEMBL6644815 0.85 LMNA (0.38) ALDH1A1LMNAKMT2AF2SMN1; SMN2
SCHEMBL6643377 0.79 ALDH1A1 (0.43) ALDH1A1LMNAMAPTKMT2AGAA
SCHEMBL6081269 0.78 ALDH1A1 (0.57) ALDH1A1LMNAMAPTKMT2AMEN1
SCHEMBL27678360 0.77 ALDH1A1 (0.44) ALDH1A1LMNAMAPTGAAMAPK1
SCHEMBL6645000 0.76 ALDH1A1 (0.37) ALDH1A1LMNAMAPTF2POLB
SCHEMBL6489438 0.76 POLB (0.51) ALDH1A1LMNAKMT2AMEN1F2
SCHEMBL2379512 0.76 KCNJ1 (0.45) ALDH1A1LMNAMAPTKMT2AMEN1
SCHEMBL4964090 0.74 ALDH1A1 (0.39) ALDH1A1LMNAMAPTGAAF2
SCHEMBL8727987 0.74 ALDH1A1 (0.48) ALDH1A1LMNAMAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040133008-A1 Amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040133008-A1 Amide compounds APOB, APOL1, LDLR ALDH1A1 2174/4885LMNA 1410/4885MAPT 4101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.